Medivir AB: Marketing Authorization Application for Lipsovir(R) Submitted to European Regulatory Authorities

October 23, 2008 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

STOCKHOLM, Sweden--(BUSINESS WIRE)--Regulatory News: Medivir (STO:MVIRB) has now submitted an application for marketing authorization to the European regulatory authorities for Lipsovir®, a topical product for prevention and treatment of cold sores.

Twitter
LinkedIn
Facebook
Email
Print

Regulatory Europe